All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a Healthcare Professional. If you are a patient or carer, please visit Know AML.

The AML Hub uses cookies on this website. They help us give you the best online experience. By continuing to use our website without changing your cookie settings, you agree to our use of cookies in accordance with our updated Cookie Policy

Introducing

Now you can personalise
your AML Hub experience!

Bookmark content to read later

Select your specific areas of interest

View content recommended for you

Find out more
  TRANSLATE

The AML Hub website uses a third-party service provided by Google that dynamically translates web content. Translations are machine generated, so may not be an exact or complete translation, and the AML Hub cannot guarantee the accuracy of translated content. The AML Hub and its employees will not be liable for any direct, indirect, or consequential damages (even if foreseeable) resulting from use of the Google Translate feature. For further support with Google Translate, visit Google Translate Help.

Steering CommitteeAbout UsNewsletterContact
Visit:
ALL Hub

ALL Hub

GvHD Hub

GvHD Hub

Lupus Hub

Lupus Hub

Lymphoma Hub

Lymphoma Hub

MPN Hub

MPN Hub

Multiple Myeloma

Multiple Myeloma Hub

PsOPsA Hub

PsOPsA Hub

LOADING
You're logged in! Click here any time to manage your account or log out.
LOADING
You're logged in! Click here any time to manage your account or log out.
Steering CommitteeAbout UsNewsletterContact
TypesTherapeuticsCongressesTrialsExpert OpinionsDRUG UPDATES
2021-12-18T16:15:44.000Z

How can venetoclax combinations be used in preparation for transplant?

By Marcia Rato
Featured
Curtis Lachowiez
Dec 18, 2021
Share:

Bookmark this article

During the 63rd ASH Annual Meeting and Exposition, the AML Hub was pleased to speak with Curtis Lachowiez, MD Anderson Cancer Center, Houston, US. We asked, How can venetoclax combinations be used in preparation for transplant? Lachowiez begins by giving background on venetoclax and recent studies around it.

How can venetoclax combinations be used in preparation for transplant?

He highlights that venetoclax deepens the depth of response to chemotherapy regimens, as shown in Courtney DiNardo's recent study. He goes on to discuss the significance of MRD negativity in AML, and further studies conducted by Nicholas Short and Farhad Ravandi. Finally, Lachowiez outlines different combination regimens and age/risk categories.

 

More about...
ASH 2021ChemotherapyVenetoclax

Related articles

Add bookmark

How can venetoclax combinations improve outcome for FLT3-mutant AML?

During the 63rd ASH Annual Meeting and Exposition, the AML Hub was pleased to speak with Naval Daver, MD Anderson Cancer Center, Houston, US. We asked, How can venetoclax...

Feb 25, 2022
Add bookmark

How can venetoclax combinations improve outcome for FLT3-mutant AML?

During the 63rd ASH Annual Meeting and Exposition, the AML Hub was pleased to speak with Naval Daver, MD Anderson Cancer Center,...

Feb 25, 2022
Add bookmark

What does real-world data tell us about frontline therapy with CPX-351 vs venetoclax + azacitidine?

During the 63rd ASH Annual Meeting and Exposition, the AML Hub was pleased to speak with Andrew Matthews, University of Pennsylvania, Philadelphia,...

Feb 2, 2022
Add bookmark

What does real-world data tell us about frontline therapy with CPX-351 vs venetoclax + azacitidine?

During the 63rd ASH Annual Meeting and Exposition, the AML Hub was pleased to speak with Andrew...

Feb 2, 2022

Newsletter

Subscribe to get the best content related to AML delivered to your inbox